Exodus Point Capital Management, LP Cytom X Therapeutics, Inc. Transaction History

Exodus Point Capital Management, LP

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$1.41 - $2.74 $15,579 - $30,274	11,049 New	11,049 $24,000
Q3 2022 Nov 10, 2022	SELL	$1.23 - $1.97 $200,477 - $321,090	-162,990 Closed	0 $0
Q2 2022 Aug 19, 2022	BUY	$1.53 - $2.89 $207,789 - $392,490	135,810 Added 499.67%	162,990 $298,000
Q1 2022 May 13, 2022	SELL	$2.67 - $4.68 $214,093 - $375,265	-80,185 Reduced 74.68%	27,180 $73,000
Q4 2021 Feb 11, 2022	BUY	$3.87 - $7.39 $270,408 - $516,361	69,873 Added 186.37%	107,365 $465,000
Q3 2021 Nov 15, 2021	BUY	$4.32 - $6.43 $48,677 - $72,453	11,268 Added 42.97%	37,492 $191,000
Q2 2021 Aug 16, 2021	BUY	$6.33 - $9.91 $165,997 - $259,879	26,224 New	26,224 $166,000
Q1 2021 May 17, 2021	SELL	$6.6 - $9.0 $275,404 - $375,552	-41,728 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$6.47 - $7.9 $80,001 - $97,683	12,365 Added 42.11%	41,728 $273,000
Q3 2020 Nov 16, 2020	BUY	$6.55 - $8.83 $84,449 - $113,845	12,893 Added 78.28%	29,363 $195,000
Q2 2020 Aug 14, 2020	BUY	$7.4 - $14.64 $121,878 - $241,120	16,470 New	16,470 $137,000
Q1 2020 May 15, 2020	SELL	$3.61 - $8.6 $122,303 - $291,359	-33,879 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$5.17 - $8.91 $21,946 - $37,822	4,245 Added 14.32%	33,879 $282,000
Q3 2019 Nov 14, 2019	BUY	$7.38 - $12.25 $65,711 - $109,074	8,904 Added 42.95%	29,634 $219,000
Q2 2019 Aug 14, 2019	BUY	$9.35 - $11.41 $193,825 - $236,529	20,730 New	20,730 $233,000

50.2M

22.3K

22.9K

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $77.8M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.